Viewing Study NCT05397093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2026-02-22 @ 8:52 PM
Study NCT ID: NCT05397093
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-05
First Post: 2022-05-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: ITIL-306 in Advanced Solid Tumors
Sponsor: Instil Bio
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Epithelial Ovarian Cancer View
None Non-small Cell Lung Cancer View
None Renal Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ITIL-306 View
None Cell Therapy View
None Epithelial ovarian cancer (EOC) View
None Non-small cell lung cancer (NSCLC) View
None Renal cell carcinoma (RCC) View
None Fallopian tube carcinoma View
None Tumor Infiltrating Lymphocytes View
None TIL View
None T-cell therapy View
None Folate receptor α (FOLR1) View
None Anti-folate receptor α (FOLR1) View
None Autologous Adoptive Cell Therapy View
None Checkpoint, PD-1 axis inhibitor View
None Peritoneal carcinoma View
None Cellular Immunotherapy View
None Immuno-oncology View
None Costimulatory antigen receptor (CoStAR) View